MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. [electronic resource]
Producer: 20180222Description: 2262-2268 p. digitalISSN:- 1539-2864
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Choroid -- pathology
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Fluorescein Angiography -- methods
- Follow-Up Studies
- Fundus Oculi
- Humans
- Intravitreal Injections
- Macula Lutea -- pathology
- Middle Aged
- Organ Size
- Prospective Studies
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Time Factors
- Tomography, Optical Coherence -- methods
- Treatment Outcome
- Visual Acuity
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.